Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04061746 · ClinicalTrials.gov registry record · Phase 1
Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
A Phase 1 study of Diabetes Mellitus, Type 1, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT04061746 is a Phase 1 study of Diabetes Mellitus, Type 1 that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 60 participants, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04061746, a Phase 1 study of Diabetes Mellitus, Type 1, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine the safety and efficacy of fresh metabolically active allogeneic umbilical cord-derived mesenchymal stromal cells (UC-MSCs) for the treatment of new-onset type 1 diabetes (T1D) and to understand the mechanisms of protection. If proven effective, such a strategy can be used as a therapeutic option for T1D patients and potentially other autoimmune disorders.
Conditions Studied
Interventions
- BIOLOGICAL Mesenchymal Stem Cells (MSCs)
- OTHER Placebo Infusion (Plasmalyte A with 0.5% human serum albumin)
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-02-27 |
| Est. Completion | 2027-03-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04061746
The ClinicalTrials.gov registry entry for NCT04061746 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (95% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 2 interventions - of which Mesenchymal Stem Cells (MSCs) is the first listed.
NCT04061746 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT04061746 about?
NCT04061746 is a clinical study titled "Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells". The goal of this study is to determine the safety and efficacy of fresh metabolically active allogeneic umbilical cord-derived mesenchymal stromal cells (UC-MSCs) for the treatment of new-onset type 1 diabetes (T1D) and to understand the mechanisms of protection. If proven effective, such a strategy...
What is the current status of trial NCT04061746?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2020-02-27. Estimated completion is 2027-03-31.
What conditions does trial NCT04061746 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.
What interventions are being tested in trial NCT04061746?
The interventions under investigation include: Mesenchymal Stem Cells (MSCs) (BIOLOGICAL), Placebo Infusion (Plasmalyte A with 0.5% human serum albumin) (OTHER).
Who is sponsoring clinical trial NCT04061746?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04061746 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes
RECRUITING · Phase 1
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes
RECRUITING · Phase 1
-
Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
RECRUITING · Phase 1
-
Allogenic Islet Cell Transplantation
ACTIVE NOT RECRUITING · Phase 1
-
Islet Transplantation for Patients With Type 1 Diabetes
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.